Skip to main content
Caplight Logo









21st.BIO

21st.BIO

Private
DenmarkHealthcare & Life Scienceshttps://21st.bio/

Last Round

VC Round

Dec 21, 2021

Momentum

Top 5%

of companies Caplight tracks

Company Overview

21st.BIO is a bioindustrial company that provides a precision fermentation technology platform to help companies scale up from laboratory-level molecule innovation to cost-effective, large-scale production.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

precision fermentationindustrial biotechnologybioprocessingstrain developmentscale-up servicesalternative proteinscellular agriculturebiomanufacturingfermentation technologymicrobial cell factorydownstream processingfood techtechnology licensingregulatory supportsynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

21st.BIO Comparables

Compare 21st.BIO with similar companies based on industry and business-model similarity.

21st.BIO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cauldron
82%
Perfect Day
78%
The Protein Express
77%

21st.BIO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 21, 2021

Key People

Founding team and executive leadership

Thomas T. Kabel

Group CFO

Executive Team

21st.BIO Investors

Notable investors and investment history

21st.BIO investors
InvestorRounds
Novo HoldingsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 17, representing 26% of headcount.

  • Jul 20, 2026

    Open roles increased to 17, 26% of headcount.

21st.BIO Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

21st.BIO Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 21st.BIO's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenmark
Employee Range69
Year Founded2020
Last FundingDec 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?